We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Atrophy

News List

Tau-PET Signal Predicts Atrophy in Early Alzheimer Disease drugs
January 03, 2020
The global intensity of the tau-positron emission tomography (PET) signal predicts the rate of subsequent atrophy in patients at early symptomatic Alzheimer disease (AD) stages ...
Serum Biomarker Linked to Brain Atrophy in Multiple Sclerosis drugs
September 12, 2019
Serum neurofilament light chain (sNFL) levels are significantly associated with clinical and neuroimaging outcomes in multiple sclerosis (MS), according to a study published online in JAMA Neurology.
Lifesaving Drug for Infants Costs $2.1 Million a Dose drugs
July 30, 2019
Its extremely high price tag means that a lifesaving medication to treat young children with spinal muscular atrophy is simply too expensive for most families.
Gene therapy medication provides improvements in severe SMA europeanpharmaceuticalreview
April 26, 2019
Spinraza, the gene therapy medication, also provides significant improvements in cases with the next most severe form of the spinal muscular atrophy…
Nusinersen Promising for Later-Onset Spinal Muscular Atrophy drugs
April 25, 2019
Nusinersen Promising for Later-Onset Spinal Muscular Atrophy.